Shuo Leng

852 total citations
11 papers, 684 citations indexed

About

Shuo Leng is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shuo Leng has authored 11 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shuo Leng's work include Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (3 papers). Shuo Leng is often cited by papers focused on Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (3 papers). Shuo Leng collaborates with scholars based in China, United States and Australia. Shuo Leng's co-authors include Honghong Yao, Bing Han, Yuan Zhang, Fangfang Wu, John H. Zhang, Xufeng Chen, Ying Bai, Jie Chao, Gang Hu and Yanhong Zhang and has published in prestigious journals such as Advanced Materials, Journal of Neuroscience and Carcinogenesis.

In The Last Decade

Shuo Leng

10 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuo Leng China 8 522 423 102 78 54 11 684
Anil K. Chokkalla United States 16 482 0.9× 322 0.8× 114 1.1× 66 0.8× 35 0.6× 32 698
Zhengli Di China 11 346 0.7× 190 0.4× 94 0.9× 62 0.8× 27 0.5× 22 549
Weijia Fan China 11 305 0.6× 196 0.5× 90 0.9× 124 1.6× 19 0.4× 22 517
Da Zhi Liu United States 8 245 0.5× 189 0.4× 97 1.0× 57 0.7× 36 0.7× 8 432
Ya Lv China 10 307 0.6× 175 0.4× 127 1.2× 43 0.6× 50 0.9× 13 568
PhilipV Peplow New Zealand 12 261 0.5× 188 0.4× 59 0.6× 24 0.3× 50 0.9× 14 440
Xiaoyang Lu China 12 234 0.4× 127 0.3× 73 0.7× 39 0.5× 55 1.0× 21 531
Dongguo Li China 13 206 0.4× 122 0.3× 46 0.5× 61 0.8× 36 0.7× 26 426
Zhongqi Bu China 7 262 0.5× 178 0.4× 56 0.5× 62 0.8× 11 0.2× 8 389
Savan Kabaria United States 8 430 0.8× 270 0.6× 32 0.3× 117 1.5× 108 2.0× 18 624

Countries citing papers authored by Shuo Leng

Since Specialization
Citations

This map shows the geographic impact of Shuo Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Leng more than expected).

Fields of papers citing papers by Shuo Leng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Leng. The network helps show where Shuo Leng may publish in the future.

Co-authorship network of co-authors of Shuo Leng

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Leng. A scholar is included among the top collaborators of Shuo Leng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Leng. Shuo Leng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Qiao, Rui, Daxing Li, Wenjing Chen, et al.. (2025). Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets. MedComm. 6(9). e70329–e70329.
2.
Leng, Shuo, et al.. (2025). The endovascular treatment strategies of cerebrovascular injuries in traumatic brain injury. Chinese Journal of Traumatology. 28(2). 81–90. 2 indexed citations
3.
Jia, Yanpeng, Xu Lian, Shuo Leng, et al.. (2025). Nose‐to‐Brain Delivery of Circular RNA SCMH1‐Loaded Lipid Nanoparticles for Ischemic Stroke Therapy. Advanced Materials. 37(19). e2500598–e2500598. 14 indexed citations
4.
Zhang, Yin, Shuo Leng, Yuanyuan Ma, et al.. (2024). The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle. Neurobiology of Disease. 192. 106426–106426. 35 indexed citations
5.
Zuo, Lei, Jian Xie, Yun Liu, et al.. (2021). Down-regulation of circular RNA CDC14A peripherally ameliorates brain injury in acute phase of ischemic stroke. Journal of Neuroinflammation. 18(1). 283–283. 29 indexed citations
6.
Zhang, Yuan, Xiaotian Zhang, Shuo Leng, et al.. (2020). Correction to: Activation of Sigma-1 Receptor Enhanced Pericyte Survival Via the Interplay between Apoptosis and Autophagy: Implications for Blood–Brain Barrier Integrity in Stroke. Translational Stroke Research. 12(4). 689–690. 3 indexed citations
7.
Wang, Guangtian, Bing Han, Ling Shen, et al.. (2020). Silencing of circular RNA HIPK2 in neural stem cells enhances functional recovery following ischaemic stroke. EBioMedicine. 52. 102660–102660. 41 indexed citations
8.
Zhang, Yuan, Xiaotian Zhang, Shuo Leng, et al.. (2019). Activation of Sigma-1 Receptor Enhanced Pericyte Survival via the Interplay Between Apoptosis and Autophagy: Implications for Blood–Brain Barrier Integrity in Stroke. Translational Stroke Research. 11(2). 267–287. 52 indexed citations
9.
Wu, Fangfang, Bing Han, Shusheng Wu, et al.. (2019). Circular RNA TLK1 Aggravates Neuronal Injury and Neurological Deficits after Ischemic Stroke via miR-335-3p/TIPARP. Journal of Neuroscience. 39(37). 7369–7393. 172 indexed citations
10.
Han, Bing, Yuan Zhang, Yanhong Zhang, et al.. (2018). Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke. Autophagy. 14(7). 1164–1184. 312 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026